This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Feb;21(1):1-3.

doi: 10.1016/j.semcancer.2011.01.003. Epub 2011 Feb 3.

Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy

Fei Chen

PMID: 21296670
DOI: 10.1016/j.semcancer.2011.01.003

Editorial

Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy

Fei Chen. Semin Cancer Biol. 2011 Feb.

. 2011 Feb;21(1):1-3.

doi: 10.1016/j.semcancer.2011.01.003. Epub 2011 Feb 3.

Author

Fei Chen

PMID: 21296670
DOI: 10.1016/j.semcancer.2011.01.003

No abstract available

PubMed Disclaimer

Similar articles

Molecular biological diagnosis and gene therapy of hepatocellular carcinoma: the present status.
Ji JF. Ji JF. Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):724-5. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12914006 No abstract available.
[The application of gene chip in the diagnosis and treatment of hepatocellular carcinoma].
Huang W, Yang DH. Huang W, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 May;12(5):317-8. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15161524 Review. Chinese. No abstract available.
Expression level of augmenter of liver regeneration in patients with hepatic failure and hepatocellular carcinoma.
Yu HY, Xiang DR, Huang HJ, Li J, Sheng JF. Yu HY, et al. Hepatobiliary Pancreat Dis Int. 2010 Oct;9(5):492-8. Hepatobiliary Pancreat Dis Int. 2010. PMID: 20943458
Fighting the bushfire in HCC trials.
Schirmacher P, Bedossa P, Roskams T, Tiniakos DG, Brunt EM, Zucman-Rossi J, Manns MP, Galle PR. Schirmacher P, et al. J Hepatol. 2011 Aug;55(2):276-7. doi: 10.1016/j.jhep.2011.03.004. Epub 2011 Mar 22. J Hepatol. 2011. PMID: 21439335 No abstract available.
Molecular diagnosis of multistage hepatocarcinogenesis.
Sakamoto M, Effendi K, Masugi Y. Sakamoto M, et al. Jpn J Clin Oncol. 2010 Sep;40(9):891-6. doi: 10.1093/jjco/hyq099. Epub 2010 Jul 4. Jpn J Clin Oncol. 2010. PMID: 20603246 Review.

See all similar articles

Cited by

Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling.
Wang Q, Na B, Ou JH, Pulliam L, Yen TS. Wang Q, et al. PLoS One. 2012;7(5):e36818. doi: 10.1371/journal.pone.0036818. Epub 2012 May 11. PLoS One. 2012. PMID: 22606292 Free PMC article.
Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2.
Zhu J, Tang B, Gao Y, Xu S, Tu J, Wang Y, Yang W, Fang S, Weng Q, Zhao Z, Xu M, Yang Y, Chen M, Lu C, Ji J. Zhu J, et al. J Inflamm Res. 2021 Aug 24;14:4089-4109. doi: 10.2147/JIR.S315957. eCollection 2021. J Inflamm Res. 2021. PMID: 34466015 Free PMC article.
Establishment of rat liver cancer cell lines with different metastatic potential.
Song L, Zhang JG, Zheng L, Feng X, Hou J, Zhang HL, Liu SF. Song L, et al. Sci Rep. 2020 May 20;10(1):8329. doi: 10.1038/s41598-020-65338-w. Sci Rep. 2020. PMID: 32433581 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information